Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/10501
Title: Adjuvant potency of Astragaloside VII embedded cholesterol nanoparticles for H3N2 influenza vaccine
Authors: Genç, Rukan
Yakuboğulları, Nilgün
Nalbantsoy, Ayşe
Coven, Fethiye
Bedir, Erdal
Keywords: Immunomodulatory activity
Nanocarriers
Cholesterol
Triterpenoid saponins
Astragaloside VII
Influenza
Issue Date: 2020
Publisher: TÜBİTAK
Abstract: Adjuvants are substances that increase the immune response to a given antigen. In the development of novel vaccine adjuvants/systems, saponins are one of the most attractive molecules due to their altered immunomodulatory activities. In this study, we tried to develop PEG (polyethylene glycol)/cholesterol-based lipid nanoparticles (LNPs) to deliver the Astragaloside VII (AST-VII) and potentiate adjuvant properties of AST-VII for the influenza vaccine. In the formation of PEG/cholesterol/AST-VII-based LNPs (PEG300: Chol-AST-VII LNPs), 3 different primary solvents (acetone, ethanol, and chloroform) were evaluated, employing their effects on hydrodynamic particle size, distribution, surface chemistry, and colloidal stability. Prepared nanoparticles were simply admixtured with inactivated influenza antigen (H3N2) and applied to PMA (phorbol 12-myristate 13-acetate)-ionomycin treated human whole blood to evaluate their cytokine release profile. PEG300: Chol-AST-VII LNPs (80.2 +/- 7.7 nm) were obtained using chloroform as a desolvation agent. Co-treatment of PMA-ionomycin with AST-VII and PEG300: Chol-AST-VII LNPs significantly increased the levels of IL-2 and IFN-gamma, compared to PMA-ionomycin alone. In the presence of H3N2, AST-VII was able to augment IL-17A, while PEG300: Chol-AST-VII LNPs stimulated the production of IFN-gamma. Hemolysis was only observed in PEG300: Chol-AST-VII LNPs (250 mu g/mL) treatment. AST-VII and AST-VII-integrated LNPs could be used as efficacious adjuvants for an inactivated H3N2 vaccine in vitro, and cytokine response through Th1/Th17 route was reported.
URI: https://doi.org/10.3906/biy-2003-49
https://hdl.handle.net/11147/10501
https://app.trdizin.gov.tr/makale/TkRNNE5EWTRPQT09
ISSN: 1300-0152
1303-6092
Appears in Collections:Bioengineering / Biyomühendislik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
TR Dizin İndeksli Yayınlar / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
Adjuvant potency.pdf4.82 MBAdobe PDFView/Open
Show full item record

CORE Recommender

WEB OF SCIENCETM
Citations

2
checked on Nov 26, 2022

Page view(s)

536
checked on Nov 14, 2022

Download(s)

6
checked on Nov 14, 2022

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.